What’s Ahead for HCV Combination Treatment? Vertical axis is SVR rate Horizontal axis is time <img src=http://ihub.bedida.net/what_lies_ahead_for_HCV.JPG> TWO NOTABLE FEATURES OF THIS TIMELINE: 1) Pegylated interferon is expected to hang around for another decade; 2) Regimens including two or more direct- antiviral agents will take a while to become the new standard of care. Source: Idenix (2006)